Key Insights
The US diabetes devices market, valued at $25.16 billion in 2025, is projected to experience robust growth, driven by rising diabetes prevalence, technological advancements in continuous glucose monitoring (CGM) and insulin delivery systems, and increasing demand for convenient and effective diabetes management solutions. The market's Compound Annual Growth Rate (CAGR) of 6.27% from 2025 to 2033 indicates a significant expansion opportunity. Key growth drivers include the increasing adoption of CGM systems offering real-time glucose data, the development of sophisticated insulin pumps with improved accuracy and features like automated insulin delivery, and the rising preference for user-friendly insulin pens and injection devices. Furthermore, the aging population and increasing awareness of diabetes management are contributing to market expansion. While potential restraints include the high cost of advanced devices and limited insurance coverage, particularly for newer technologies, the overall market trajectory remains positive, fueled by continued innovation and growing patient needs.
The competitive landscape is characterized by a mix of established players like Abbott, Medtronic, Novo Nordisk, and emerging companies specializing in innovative technologies. These companies are focusing on product differentiation through improved accuracy, ease of use, and integration with smart devices. The market is segmented into various device categories including lancets, glucose monitoring devices (CGM and SMBG), and insulin delivery systems (insulin pumps, infusion sets, pens, and jet injectors). The CGM segment is expected to witness the most significant growth owing to its ability to provide continuous glucose data, leading to improved diabetes management and reduced complications. Regional variations exist within the US market; however, nationwide growth is anticipated, driven by consistent increases in diabetes diagnosis across all regions. This data suggests significant investment potential in the diabetes devices market, particularly for companies offering advanced and user-friendly technologies.
US Diabetes Devices Market: A Comprehensive Report (2019-2033)
This comprehensive report provides a detailed analysis of the US Diabetes Devices Market, encompassing market dynamics, growth trends, competitive landscape, and future outlook. The study period covers 2019-2033, with 2025 as the base and estimated year. The report offers valuable insights for industry professionals, investors, and stakeholders seeking to understand and capitalize on opportunities within this rapidly evolving sector. The market is segmented into key areas, including Insulin Devices, Continuous Glucose Monitoring (CGM) Devices, and Self-Monitoring Blood Glucose (SMBG) Devices, providing granular analysis of each sub-segment. Market values are presented in million units.
US Diabetes Devices Market Dynamics & Structure
This section analyzes the structure and dynamics of the US diabetes devices market, examining market concentration, technological innovation, regulatory influences, competitive substitutes, and M&A activity. The market exhibits a moderately concentrated structure, with key players such as Abbott, Medtronic, Dexcom, and Novo Nordisk holding significant market shares. However, a substantial number of smaller companies and emerging players also contribute significantly to market innovation.
- Market Concentration: The Herfindahl-Hirschman Index (HHI) for the US diabetes devices market in 2024 is estimated at xx, indicating a moderately concentrated market.
- Technological Innovation: Continuous advancements in CGM technology, such as the introduction of integrated systems and improved accuracy, are major drivers of growth. Innovation in insulin delivery systems, including tubeless pumps, also contribute significantly.
- Regulatory Landscape: Stringent FDA regulations impact product development and approval timelines, creating both barriers and incentives for innovation.
- Competitive Substitutes: The market faces competition from alternative diabetes management approaches, including lifestyle changes and non-device-based therapies.
- M&A Activity: The past five years have witnessed xx major mergers and acquisitions in the US diabetes devices market, primarily driven by strategies to expand product portfolios and enhance market reach. This activity has resulted in a xx% increase in market consolidation.
- End-User Demographics: The aging population and rising prevalence of diabetes are key drivers of market growth. The increasing adoption of advanced technologies by end-users contributes to the market's growth trajectory.
US Diabetes Devices Market Growth Trends & Insights
The US diabetes devices market has experienced substantial growth in recent years, driven by factors such as increasing prevalence of diabetes, technological advancements, and rising healthcare expenditure. The market size is projected to reach xx million units by 2033, exhibiting a CAGR of xx% during the forecast period (2025-2033). This growth is influenced by rising adoption rates of advanced CGM and insulin delivery systems, improved diagnostic capabilities, and increasing awareness about diabetes management. Consumer behavior is shifting toward a preference for more convenient and integrated devices, leading to higher adoption rates of advanced technology. Technological disruptions, such as the introduction of artificial pancreas systems, are expected to further accelerate market growth. Market penetration of CGM devices is currently at xx% and is projected to reach xx% by 2033.
Dominant Regions, Countries, or Segments in US Diabetes Devices Market
The US diabetes devices market is geographically widespread, with significant contributions from various regions. However, the major growth is attributed to the high prevalence of diabetes in specific regions like the South and West Coast areas. Within the segments, Continuous Glucose Monitoring (CGM) devices are the fastest growing segment due to their superior accuracy and ease of use. Insulin pumps also demonstrate considerable growth potential.
- Leading Segment: Continuous Glucose Monitoring (CGM) devices are experiencing the highest growth due to increasing user preference for non-invasive blood glucose monitoring methods.
- Key Drivers: Increased awareness of diabetes management, growing demand for convenient monitoring options, and advancements in CGM technology are major drivers of the segment's dominance.
- Dominance Factors: The accuracy, ease of use, and integration capabilities of CGM devices are key factors contributing to their dominance.
- Market Share and Growth Potential: CGM devices held a xx% market share in 2024 and are projected to reach xx% by 2033, driven by high growth potential.
US Diabetes Devices Market Product Landscape
The US diabetes devices market offers a diverse range of products, including insulin pumps, continuous glucose monitors (CGMs), self-monitoring blood glucose (SMBG) devices, lancets, insulin syringes, infusion sets, and insulin pens. Recent innovations focus on improved accuracy, convenience, and integration of devices for seamless diabetes management. Features like smaller device sizes, wireless connectivity, and data integration with mobile apps are significant selling propositions. Technological advancements in sensor technology, algorithm development, and miniaturization continue to drive product innovation.
Key Drivers, Barriers & Challenges in US Diabetes Devices Market
Key Drivers:
- The rising prevalence of diabetes is the primary driver.
- Technological advancements leading to more accurate, user-friendly devices.
- Increased healthcare expenditure and insurance coverage for diabetes management.
Key Challenges and Restraints:
- High cost of devices restricts accessibility for a significant portion of the population.
- Regulatory hurdles and lengthy approval processes hinder product innovation and market entry.
- Intense competition among established players and emerging companies creates pricing pressures. This competition also leads to decreased profit margins for manufacturers.
Emerging Opportunities in US Diabetes Devices Market
Emerging opportunities lie in the development of closed-loop systems (artificial pancreas), improved data analytics for personalized diabetes management, integration with telehealth platforms, and expansion into underserved populations. There’s also potential for development of advanced sensor technologies, improved insulin delivery methods, and innovative approaches to diabetes education. The development of more affordable, accessible devices in underserved areas is a key market opportunity.
Growth Accelerators in the US Diabetes Devices Market Industry
Long-term growth will be accelerated by technological breakthroughs in CGM and insulin delivery systems, strategic partnerships between device manufacturers and healthcare providers, and expansion into international markets. Increased collaboration between researchers, clinicians, and device developers will also drive innovation and market expansion. Furthermore, government initiatives promoting diabetes awareness and prevention will contribute significantly to the long-term growth.
Key Players Shaping the US Diabetes Devices Market Market
- Omnipod
- Insulin Devices
- Dexcom
- Abbott
- LifeScan
- Becton and Dickenson
- F Hoffmann-La Roche AG
- Novo Nordisk
- Medtronic
- Other Self-monitoring Blood Glucose Devices
- Other Continuous Glucose Monitoring Devices
- Other Insulin Device
- Sanofi
- Johnson & Johnson
- Ypsomed Holding
- Insulet Corporation
- Eli Lilly and Company
- Tandem
Notable Milestones in US Diabetes Devices Market Sector
- August 2023: The FDA granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free patch pump. This marks a significant advancement in insulin delivery technology, offering improved convenience and usability.
- March 2022: Dexcom launched the G7 CGM system in the U.K., with plans for a US release pending FDA approval. This highlights the ongoing innovation and expansion of CGM technology in the market.
In-Depth US Diabetes Devices Market Market Outlook
The US diabetes devices market is poised for continued strong growth, driven by technological advancements, rising diabetes prevalence, and increasing healthcare expenditure. Strategic opportunities lie in developing integrated solutions, expanding telehealth capabilities, and focusing on personalized diabetes management. The market's future potential is significant, particularly in the areas of closed-loop systems and improved data analytics, promising substantial returns for investors and significant improvements in the lives of people with diabetes.
US Diabetes Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
US Diabetes Devices Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
US Diabetes Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.27% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Growing Diabetes and Obesity Population in the United States
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring
- 9.1.2.1. Sensors
- 9.1.2.2. Durables
- 9.1.1. Self-monitoring Blood Glucose
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring
- 10.1.2.1. Sensors
- 10.1.2.2. Durables
- 10.1.1. Self-monitoring Blood Glucose
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Northeast US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 12. Southeast US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 13. Midwest US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. Southwest US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. West US Diabetes Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 1 Omnipod
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Insulin Devices
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 4 Other Continuous Glucose Monitoring Devices
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 3 LifeScan
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 1 Dexcom
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Becton and Dickenson
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 3 Abbott
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 F Hoffmann-La Roche AG
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 2 Novo Nordisk
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 2 Medtronic
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 4 Other Self-monitoring Blood Glucose Devices
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Abbott
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Self-monitoring Blood Glucose Devices
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.14 Novo Nordisk
- 16.2.14.1. Overview
- 16.2.14.2. Products
- 16.2.14.3. SWOT Analysis
- 16.2.14.4. Recent Developments
- 16.2.14.5. Financials (Based on Availability)
- 16.2.15 Eli Lilly and Company*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 16.2.15.1. Overview
- 16.2.15.2. Products
- 16.2.15.3. SWOT Analysis
- 16.2.15.4. Recent Developments
- 16.2.15.5. Financials (Based on Availability)
- 16.2.16 Sanofi
- 16.2.16.1. Overview
- 16.2.16.2. Products
- 16.2.16.3. SWOT Analysis
- 16.2.16.4. Recent Developments
- 16.2.16.5. Financials (Based on Availability)
- 16.2.17 Johnson & Johnson
- 16.2.17.1. Overview
- 16.2.17.2. Products
- 16.2.17.3. SWOT Analysis
- 16.2.17.4. Recent Developments
- 16.2.17.5. Financials (Based on Availability)
- 16.2.18 Ypsomed Holding
- 16.2.18.1. Overview
- 16.2.18.2. Products
- 16.2.18.3. SWOT Analysis
- 16.2.18.4. Recent Developments
- 16.2.18.5. Financials (Based on Availability)
- 16.2.19 Medtronic
- 16.2.19.1. Overview
- 16.2.19.2. Products
- 16.2.19.3. SWOT Analysis
- 16.2.19.4. Recent Developments
- 16.2.19.5. Financials (Based on Availability)
- 16.2.20 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 16.2.20.1. Overview
- 16.2.20.2. Products
- 16.2.20.3. SWOT Analysis
- 16.2.20.4. Recent Developments
- 16.2.20.5. Financials (Based on Availability)
- 16.2.21 2 F Hoffmann-La Roche AG
- 16.2.21.1. Overview
- 16.2.21.2. Products
- 16.2.21.3. SWOT Analysis
- 16.2.21.4. Recent Developments
- 16.2.21.5. Financials (Based on Availability)
- 16.2.22 3 Johnson & Johnson
- 16.2.22.1. Overview
- 16.2.22.2. Products
- 16.2.22.3. SWOT Analysis
- 16.2.22.4. Recent Developments
- 16.2.22.5. Financials (Based on Availability)
- 16.2.23 Dexcom
- 16.2.23.1. Overview
- 16.2.23.2. Products
- 16.2.23.3. SWOT Analysis
- 16.2.23.4. Recent Developments
- 16.2.23.5. Financials (Based on Availability)
- 16.2.24 1 Abbott
- 16.2.24.1. Overview
- 16.2.24.2. Products
- 16.2.24.3. SWOT Analysis
- 16.2.24.4. Recent Developments
- 16.2.24.5. Financials (Based on Availability)
- 16.2.25 Continuous Glucose Monitoring Devices
- 16.2.25.1. Overview
- 16.2.25.2. Products
- 16.2.25.3. SWOT Analysis
- 16.2.25.4. Recent Developments
- 16.2.25.5. Financials (Based on Availability)
- 16.2.26 Tandem
- 16.2.26.1. Overview
- 16.2.26.2. Products
- 16.2.26.3. SWOT Analysis
- 16.2.26.4. Recent Developments
- 16.2.26.5. Financials (Based on Availability)
- 16.2.27 4 Other Insulin Device
- 16.2.27.1. Overview
- 16.2.27.2. Products
- 16.2.27.3. SWOT Analysis
- 16.2.27.4. Recent Developments
- 16.2.27.5. Financials (Based on Availability)
- 16.2.28 Insulet Corporation
- 16.2.28.1. Overview
- 16.2.28.2. Products
- 16.2.28.3. SWOT Analysis
- 16.2.28.4. Recent Developments
- 16.2.28.5. Financials (Based on Availability)
- 16.2.1 1 Omnipod
List of Figures
- Figure 1: Global US Diabetes Devices Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: United states US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 3: United states US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 4: North America US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 5: North America US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 6: North America US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 7: North America US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 8: North America US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 9: North America US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 11: South America US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 12: South America US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 13: South America US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 14: South America US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 15: South America US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 16: Europe US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 17: Europe US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 18: Europe US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 19: Europe US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 20: Europe US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 23: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 24: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 25: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 26: Middle East & Africa US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 27: Middle East & Africa US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific US Diabetes Devices Market Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 29: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 30: Asia Pacific US Diabetes Devices Market Revenue (Million), by Management Devices 2024 & 2032
- Figure 31: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Management Devices 2024 & 2032
- Figure 32: Asia Pacific US Diabetes Devices Market Revenue (Million), by Country 2024 & 2032
- Figure 33: Asia Pacific US Diabetes Devices Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global US Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Global US Diabetes Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Northeast US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: Southeast US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Midwest US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Southwest US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: West US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 12: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 13: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: United States US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Canada US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 18: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 19: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 20: Brazil US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Argentina US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Rest of South America US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 24: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 25: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 26: United Kingdom US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Germany US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: France US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Italy US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Spain US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Russia US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Benelux US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 33: Nordics US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Rest of Europe US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 36: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 37: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 38: Turkey US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Israel US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: GCC US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 41: North Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: South Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: Rest of Middle East & Africa US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Global US Diabetes Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 45: Global US Diabetes Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 46: Global US Diabetes Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 47: China US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: India US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Japan US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: South Korea US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 51: ASEAN US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Oceania US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 53: Rest of Asia Pacific US Diabetes Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the US Diabetes Devices Market?
The projected CAGR is approximately 6.27%.
2. Which companies are prominent players in the US Diabetes Devices Market?
Key companies in the market include 1 Omnipod, Insulin Devices, 4 Other Continuous Glucose Monitoring Devices, 3 LifeScan, 1 Dexcom, Becton and Dickenson, 3 Abbott, F Hoffmann-La Roche AG, 2 Novo Nordisk, 2 Medtronic, 4 Other Self-monitoring Blood Glucose Devices, Abbott, Self-monitoring Blood Glucose Devices, Novo Nordisk, Eli Lilly and Company*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Sanofi, Johnson & Johnson, Ypsomed Holding, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, 2 F Hoffmann-La Roche AG, 3 Johnson & Johnson, Dexcom, 1 Abbott, Continuous Glucose Monitoring Devices, Tandem, 4 Other Insulin Device, Insulet Corporation.
3. What are the main segments of the US Diabetes Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 25.16 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Growing Diabetes and Obesity Population in the United States.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
August 2023: The US Food and Drug Administration (FDA) has granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "US Diabetes Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the US Diabetes Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the US Diabetes Devices Market?
To stay informed about further developments, trends, and reports in the US Diabetes Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
